Published in J Exp Med on July 01, 1991
Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci U S A (1994) 3.07
Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time. Immunity (2010) 2.82
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med (1994) 2.61
Translational diffusion of individual class II MHC membrane proteins in cells. Biophys J (2002) 2.37
Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J Exp Med (1993) 2.27
Separation of subcellular compartments containing distinct functional forms of MHC class II. J Cell Biol (1994) 2.09
Electrical manipulation of glycan-phosphatidyl inositol-tethered proteins in planar supported bilayers. Biophys J (1996) 1.86
GPI- and transmembrane-anchored influenza hemagglutinin differ in structure and receptor binding activity. J Cell Biol (1993) 1.78
Cholesterol depletion suppresses the translational diffusion of class II major histocompatibility complex proteins in the plasma membrane. Biophys J (2004) 1.78
Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules. J Exp Med (1996) 1.66
Kinetics and extent of T cell activation as measured with the calcium signal. J Exp Med (1997) 1.51
Both MHC class II and its GPI-anchored form undergo hop diffusion as observed by single-molecule tracking. Biophys J (2008) 1.50
Cholesterol depletion induces solid-like regions in the plasma membrane. Biophys J (2005) 1.44
Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J Exp Med (1999) 1.38
pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. EMBO J (1992) 1.36
Dependence of T cell antigen recognition on the dimensions of an accessory receptor-ligand complex. J Exp Med (1999) 1.35
T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen. J Exp Med (1993) 1.31
Activation and differentiation requirements of primary T cells in vitro. Proc Natl Acad Sci U S A (1993) 1.29
Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J (1996) 1.28
Abundant empty class II MHC molecules on the surface of immature dendritic cells. Proc Natl Acad Sci U S A (1999) 1.26
Generation of a water-soluble oligomeric ectodomain of the Rous sarcoma virus envelope glycoprotein. J Virol (1993) 1.25
CD80 cytoplasmic domain controls localization of CD28, CTLA-4, and protein kinase Ctheta in the immunological synapse. J Immunol (2005) 1.20
Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface. J Exp Med (1996) 1.13
Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced in Escherichia coli. Proc Natl Acad Sci U S A (1993) 1.13
Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH. J Exp Med (1994) 1.06
Long-lived complexes between peptide and class II major histocompatibility complex are formed at low pH with no requirement for pH neutralization. J Exp Med (1992) 1.02
A structural transition in class II major histocompatibility complex proteins at mildly acidic pH. J Exp Med (1996) 0.97
Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins. Proc Natl Acad Sci U S A (1997) 0.95
A T cell receptor-specific blockade of positive selection. J Exp Med (1999) 0.93
Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced. J Exp Med (1996) 0.92
Catalysis of peptide dissociation from class II MHC-peptide complexes. Proc Natl Acad Sci U S A (1999) 0.85
Biochemical evidence for the rapid assembly and disassembly of processed antigen-major histocompatibility complex class II complexes in acidic vesicles of B cells. J Exp Med (1992) 0.83
Functional evidence for TCR-intrinsic specificity for MHCII. Proc Natl Acad Sci U S A (2016) 0.81
GPI-anchored diphtheria toxin receptor allows membrane translocation of the toxin without detectable ion channel activity. EMBO J (1996) 0.80
Membrane interactions influence the peptide binding behavior of DR1. J Exp Med (1994) 0.80
Differing processing requirements of four recombinant antigens containing a single defined T-cell epitope for presentation by major histocompatibility complex class II. Immunology (2001) 0.80
MHC class II-bound self-peptides can be effectively separated by isoelectric focusing and bind optimally to their MHC class II restriction elements around pH 5.0. Immunology (1994) 0.78
Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal. J Exp Med (1998) 0.77
Supported Lipid Bilayer Technology for the Study of Cellular Interfaces. Curr Protoc Cell Biol (2015) 0.76
Costimulation of IL-2 Production through CD28 Is Dependent on the Size of Its Ligand. J Immunol (2015) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem (1981) 29.21
T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol (1978) 28.92
Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res (1987) 12.80
Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol (1980) 8.56
Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures. Annu Rev Biochem (1988) 7.57
Continuous proliferation of murine antigen-specific helper T lymphocytes in culture. J Exp Med (1979) 7.20
T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol (1985) 6.98
The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med (1983) 5.74
The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science (1987) 5.32
Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A (1982) 4.85
Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell (1986) 4.71
The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell (1990) 4.18
High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature (1989) 3.99
Monoclonal antibody against an Ir gene product? J Exp Med (1980) 3.88
Correlations between T-cell specificity and the structure of the antigen receptor. Nature (1986) 3.83
Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid. Proc Natl Acad Sci U S A (1983) 3.66
Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature (1990) 3.44
The fine specificity of antigen and Ia determinant recognition by T cell hybridoma clones specific for pigeon cytochrome c. Cell (1982) 3.38
The murine E alpha immune response gene. Cell (1983) 2.86
Signal for attachment of a phospholipid membrane anchor in decay accelerating factor. Science (1987) 2.59
Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science (1990) 2.56
Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J Exp Med (1986) 2.55
Cloning, sequencing, and chromosomal localization of human term placental alkaline phosphatase cDNA. Proc Natl Acad Sci U S A (1985) 2.44
Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J (1990) 2.42
Interaction between a "processed" ovalbumin peptide and Ia molecules. Proc Natl Acad Sci U S A (1986) 2.42
Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature (1990) 2.40
Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J Biol Chem (1987) 2.27
Requirements for the processing of antigens by antigen-presenting B cells. I. Functional comparison of B cell tumors and macrophages. J Immunol (1982) 2.25
Antigen recognition. Class discrimination in the world of immunology. Nature (1987) 2.10
Autologous peptides constitutively occupy the antigen binding site on Ia. Science (1988) 1.92
A kinetic intermediate in the reaction of an antigenic peptide and I-Ek. Nature (1989) 1.89
Cell-specific heterogeneity in sensitivity of phosphatidylinositol-anchored membrane antigens to release by phospholipase C. J Immunol Methods (1988) 1.85
High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. J Immunol (1990) 1.85
Acidification of morphologically distinct endosomes in mutant and wild-type Chinese hamster ovary cells. J Cell Biol (1987) 1.82
Aspartic acid-484 of nascent placental alkaline phosphatase condenses with a phosphatidylinositol glycan to become the carboxyl terminus of the mature enzyme. Proc Natl Acad Sci U S A (1988) 1.64
Structural intermediates in the reactions of antigenic peptides with MHC molecules. Cold Spring Harb Symp Quant Biol (1989) 1.61
Functional and ultrastructural evidence for intracellular formation of major histocompatibility complex class II-peptide complexes during antigen processing. Proc Natl Acad Sci U S A (1990) 1.60
Isolation and characterization of a cDNA clone for the murine I-E beta polypeptide chain. Proc Natl Acad Sci U S A (1983) 1.54
Regulation of antigen presentation by acidic pH. J Exp Med (1990) 1.46
Turnover of Ia-peptide complexes is facilitated in viable antigen-presenting cells: biosynthetic turnover of Ia vs. peptide exchange. Proc Natl Acad Sci U S A (1989) 1.31
Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit association. J Biol Chem (1977) 1.24
T lymphocyte response to bacteriophage lambda repressor cI protein. Recognition of the same peptide presented by Ia molecules of different haplotypes. J Immunol (1987) 1.23
Fluorometric assays for avidin and biotin. Methods Enzymol (1986) 1.22
Functionally distinct agretopic and epitopic sites. Analysis of the dominant T cell determinant of moth and pigeon cytochromes c with the use of synthetic peptide antigens. J Immunol (1987) 1.18
Thymic cortical epithelial cells can present self-antigens in vivo. Nature (1989) 1.13
Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3' end sequence of decay-accelerating factor's mRNA. Proc Natl Acad Sci U S A (1988) 1.13
Ia molecule-associated selectivity in T cell recognition of a 23-amino-acid peptide of lysozyme. J Exp Med (1986) 1.11
Diminished antigen processing by endosomal acidification mutant antigen-presenting cells. J Immunol (1989) 1.08
Antigen-presenting function of B lymphocytes. Immunol Rev (1988) 1.06
Phospholipids enhance the binding of peptides to class II major histocompatibility molecules. Proc Natl Acad Sci U S A (1990) 1.05
Solid-phase binding of class I and II MHC proteins: immunoassay and T cell recognition. Mol Immunol (1989) 0.97
Class II MHC molecules are spontaneously internalized in acidic endosomes by activated B cells. J Mol Cell Immunol (1990) 0.87
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
The immunological synapse: a molecular machine controlling T cell activation. Science (1999) 17.41
Polymerase chain reaction with single-sided specificity: analysis of T cell receptor delta chain. Science (1989) 9.01
Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature (1984) 8.89
The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med (1992) 7.80
Depressor substances in extracts of intestine. J Physiol (1934) 7.49
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature (1990) 6.23
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med (1999) 6.09
Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins. Nature (1984) 6.08
Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol (1998) 5.11
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature (1989) 5.08
Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell (1994) 4.60
The immunological synapse. Annu Rev Immunol (2001) 4.45
Somatic recombination in a murine T-cell receptor gene. Nature (1984) 4.21
Genomic organization and sequence of T-cell receptor beta-chain constant- and joining-region genes. Nature (1984) 4.15
Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature (1992) 4.01
An immunoglobulin heavy-chain gene is formed by at least two recombinational events. Nature (1980) 3.99
A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity (1999) 3.88
A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science (1998) 3.76
DNA sequences mediating class switching in alpha-immunoglobulins. Science (1980) 3.70
Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity (2000) 3.49
Cell-type-specific cDNA probes and the murine I region: the localization and orientation of Ad alpha. Proc Natl Acad Sci U S A (1984) 3.43
The adult T-cell receptor delta-chain is diverse and distinct from that of fetal thymocytes. Nature (1988) 3.43
Antigen-specific development of primary and memory T cells in vivo. Science (1995) 3.41
Structural gene sets active in embryos and adult tissues of the sea urchin. Cell (1976) 3.38
CDR3 length in antigen-specific immune receptors. J Exp Med (1994) 3.35
Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol (1999) 3.33
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med (2000) 3.32
Differential clustering of CD4 and CD3zeta during T cell recognition. Science (2000) 3.30
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A (1999) 3.30
Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell (1989) 3.29
A third type of murine T-cell receptor gene. Nature (1984) 3.24
A human T cell-specific molecule is a member of a new gene family. J Immunol (1988) 3.21
Immunoglobulin heavy chain gene organization in mice: analysis of a myeloma genomic clone containing variable and alpha constant regions. Proc Natl Acad Sci U S A (1979) 3.19
Adrenaline in the suprarenal medulla. J Physiol (1933) 3.14
A new T-cell receptor gene located within the alpha locus and expressed early in T-cell differentiation. Nature (1987) 3.08
Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci U S A (1994) 3.07
Low affinity interaction of peptide-MHC complexes with T cell receptors. Science (1991) 2.89
Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol (1999) 2.89
T-cell receptor delta gene rearrangements in early thymocytes. Nature (1988) 2.88
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med (2000) 2.78
MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology (2000) 2.77
Structure, expression and divergence of T-cell receptor beta-chain variable regions. Nature (1984) 2.71
A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity (1996) 2.69
Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. Proc Natl Acad Sci U S A (1998) 2.69
The nature of major histocompatibility complex recognition by gamma delta T cells. Cell (1994) 2.64
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med (1994) 2.61
Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science (1990) 2.56
Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. Immunity (1998) 2.52
CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature (1995) 2.45
The immunological evolution of catalysis. Science (1996) 2.44
Aortic dissection: a comparative study of diagnosis with spiral CT, multiplanar transesophageal echocardiography, and MR imaging. Radiology (1996) 2.38
Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell Mol Life Sci (2005) 2.32
A role for the proteasome regulator PA28alpha in antigen presentation. Nature (1996) 2.30
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J Exp Med (2001) 2.27
Kinetic discrimination in T-cell activation. Proc Natl Acad Sci U S A (1996) 2.17
Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J Immunol (1994) 2.15
Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med (1995) 2.11
Getting heavier, younger: trajectories of obesity over the life course. Int J Obes (Lond) (2009) 2.09
Identification of self through two-dimensional chemistry and synapses. Annu Rev Cell Dev Biol (2001) 1.99
Molecular components of T-cell recognition. Annu Rev Immunol (1992) 1.96
Localization of a T-cell receptor diversity-region element. Nature (1984) 1.96
Regulating the retention of T-cell receptor alpha chain variants within the endoplasmic reticulum: Ca(2+)-dependent association with BiP. J Cell Biol (1991) 1.93
Not without my permission: parents' willingness to permit use of newborn screening samples for research. Public Health Genomics (2009) 1.92
Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol (1999) 1.92
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A (2001) 1.85
Identification and sequence of a fourth human T cell antigen receptor chain. Nature (1988) 1.81
Molecular genetics of the T cell-receptor beta chain. Annu Rev Immunol (1985) 1.76
Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell (1996) 1.76
Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity (1998) 1.74
T cell assays and MIATA: the essential minimum for maximum impact. Immunity (2012) 1.74
Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. Proc Natl Acad Sci U S A (1998) 1.72
Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol (2001) 1.67
Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms. N Engl J Med (1985) 1.65
Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity (1996) 1.64
Comparison of capsule endoscopy and magnetic resonance imaging for the detection of polyps of the small intestine in patients with familial adenomatous polyposis or with Peutz-Jeghers' syndrome. Endoscopy (2004) 1.64
Two new proteases in the MHC class I processing pathway. Nat Immunol (2000) 1.63
Experience with juvenile polyps in North American children: the need for pancolonoscopy. Am J Gastroenterol (2001) 1.61
Actual clinical use of gadolinium-chelates for non-MRI applications. Eur Radiol (2004) 1.60
The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol (2000) 1.59
Ligand-specific oligomerization of T-cell receptor molecules. Nature (1997) 1.58
The effects of MHC gene dosage and allelic variation on T cell receptor selection. Cell (1990) 1.58
Formation of a highly peptide-receptive state of class II MHC. Immunity (1998) 1.58
Expression of genes of the T-cell antigen receptor complex in precursor thymocytes. Nature (1985) 1.57
Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J Biol Chem (1998) 1.57
A murine T cell receptor gene complex: isolation, structure and rearrangement. Immunol Rev (1984) 1.56
T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med (1990) 1.55
A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity (1997) 1.55